Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: CEO's ARE judged based on PPS and rightly so

I think it's unfair to compare RG to any other CEO. Other CEO's run companies that already make stuff. They can be judged quicker, imo after a year I would expect to see some results. But RG took over a company that didn't make anything and has performed well imo with the amount of cash he has had to work with. The problem is that he is trying to build a company from scratch from the ground up. He's had many roadblocks thrown in the Sp's path the USPTO, Little control over the MMP, Swartz dumping, and the mismanagement of revenue by previous CEO's and now the economy.

He's invested in technology that has potential in the near future. When I say near future I mean within the next 2 years. RG said this is a very competitive environment that they compete in. With the global economy in the tank it may be even more difficult to get some of the software sold. I really think at this time PTSC needs to hunker down spend as little cash as possible and survive this difficult and vulnerable time for the company until the USPTO has completed the re-validation process and or Crossflo and the others can make some sales.

I don't know what else RG can do at this time? I don't think there is anything he can say that will make the SP move up. It's all just talk until the rubber meets the road.

All the best,

Steve

Share
New Message
Please login to post a reply